Shengmai liquid for long covid fatigue trial
Part of Brain & nervous system, Infections clinical trials.
This trial tests if a traditional Chinese medicine, Shengmai Liquid, can help reduce fatigue in people with long COVID. It is for adults aged 18 to 75 who feel tired for a long time after a COVID infection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 75 years old.
- You must have ongoing fatigue after a COVID infection (long COVID).
- You must meet the trial’s specific diagnostic criteria, including those from traditional Chinese medicine.
- You must be willing to sign a consent form.
- You cannot have severe breathing problems needing oxygen or a ventilator.
- You cannot have serious liver or kidney disease.
- You cannot have severe heart failure or a recent heart attack or stroke.
- You cannot be pregnant or breastfeeding.
- You cannot have other serious illnesses like cancer, epilepsy, or autoimmune diseases.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new supplement called CP003 to see if it helps reduce tiredness in people with chronic fatigue syndrome or long COVID fatigue.
This trial tests a natural compound to see if it can reduce ongoing inflammation and symptoms like fatigue, brain fog, or shortness of breath that linger after a COVID-19 infection. It's for people who still have symptoms at least 2 months after getting sick.
This study tests a program to help reduce fatigue and other symptoms in people with Long COVID. It involves using an internet-connected device to access the program remotely.
This study tests whether improving diet quality can reduce fatigue and symptoms in people with long-COVID (post-acute COVID-19 syndrome). It may help if your diet quality is currently low and your fatigue is moderate to severe.
This trial tests if a low dose of sirolimus, a medicine that calms the immune system, can help people with long COVID. If you have had long COVID symptoms for at least 6 months, like severe fatigue, brain fog, or chest pain, you may be able to join.
This trial is testing treatments for people with long COVID, which is when symptoms last more than 3 months after a COVID-19 infection. The trial focuses on three specific symptom groups: heart inflammation, cough, or severe fatigue with signs of inflammation. It aims to find if certain immune-modulating therapies can help.
Hear when a new Long COVID Fatigue trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.